Galderma acquires ALASTIN Skincare to enhance its dermatology platform
ALASTIN’s patented, differentiated technology and products are highly synergistic with Galderma’s premium portfolio
ALASTIN’s patented, differentiated technology and products are highly synergistic with Galderma’s premium portfolio
The platform has seen an overall growth of 84% in the number of people seeking consultations for skin-related issues
Acquisition provides direct access to the Dutch healthcare market, enhancing Marksans’ sales, distribution and market-access capabilities across regulated European markets
These data support clinically meaningful efficacy within this patient population. We observed a high rate of complete responses in patients with laCSCC
Veteran consumer health and FMCG strategist to lead preventive wellness and nutrition portfolio expansion through innovation and modern trade channels
Net income more than doubled to 2.763 billion euros, while core earnings per share climbed 12.9 percent to 2.71 euros
Industry veteran to lead Brinton’s expansion across India and key Asia Pacific markets
The company has also launched Elyara, a portfolio of products in regenerative medical aesthetics focused on non-invasive skin and hair restoration
The company says the product will now be distributed exclusively through Anovo Specialty Pharmacy
Subscribe To Our Newsletter & Stay Updated